News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
BORMANN-KENNEDY BARBARA-JEAN ANNE
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/07/2023 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.
Txns:
| Granted 42,500 shares
@ $0 |
|
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2021 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.
Txns:
| Granted 19,650 options to buy
@ $12.5, valued at
$245.6k
Granted 20,000 options to buy
@ $10, valued at
$200k
Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2021 |
3
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 3 on Xeris Biopharma Holdings, Inc. |
06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2020 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns:
| Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
|
|
03/01/2019 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns:
| Granted 20,000 options to buy
@ $10, valued at
$200k
|
|
06/20/2018 |
3
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 3 on XERIS PHARMACEUTICALS INC |
|
|